Drugs / Rabipur
Rabipur
Trials 10
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT07399951 | Oct 2023 → Jun 2025 | — | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 13 trials | ||||||
| Phase 1 | NCT04019444 | Sep 2019 → Mar 2023 | rabies | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT02458092 | Apr → Dec 2008 | malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 1 | NCT00358332 | Nov 2006 → Dec 2007 | Plasmodium falciparum malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 1/21 trial · 1 missed | ||||||
| Phase 1/2 | NCT02956746 | Aug 2016 → Dec 2017 | rabies | Synermore Biologics Co., Ltd. | Completed | Missed primary |
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT02040090 | Apr 2013 → Aug 2014 | rabies | Kamada, Ltd. | Completed | Met primary |
| Phase 33 trials · 1 met primary | ||||||
| Phase 3 | NCT02545517 | Oct 2015 → Dec 2022 | rabies | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01680016 | Sep 2012 → Jan 2013 | rabies | Novartis Vaccines | Completed | Met primary |
| Phase 3 | NCT01107275 | Nov 2002 → Nov 2004 | rabies | Provincial Public Health Office, Phetchabun | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03192371 | Feb 2018 → May 2019 | viral infectious disease | GlaxoSmithKline | Withdrawn | No outcome recorded |
| Comparator or background therapy15 trials | ||||||
| Phase 1 | NCT06048770 Comparator | Sep 2023 → Jul 2024 | — | Replicate Bioscience | Terminated | No outcome recorded Stop: Business |
| Phase 1 | NCT04062669 Comparator | Aug 2019 → Jul 2021 | viral infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT03713086 Comparator | Oct 2018 → Nov 2021 | rabies | CureVac | Completed | No outcome recorded |
| Phase 1 | NCT02657161 Comparator | Feb → Jul 2015 | rabies | Yisheng Biopharma (Singapore) Pte. Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT02238756 Comparator | Sep 2014 → Sep 2015 | rabies | CureVac | Completed | No outcome recorded |
| Phase 1 | NCT00349713 Comparator | Nov 2004 → Dec 2005 | Plasmodium falciparum malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 2 | NCT02956421 Comparator | Feb → Oct 2016 | rabies | Yisheng Biopharma (Singapore) Pte. Ltd. | Completed | Met primary |
| Phase 2 | NCT00380393 Comparator | Jan 2007 → Aug 2008 | malaria | GlaxoSmithKline | Completed | Met primary |
| Phase 2 | NCT00360230 Comparator | Aug 2006 → Aug 2007 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00197054 Comparator | Jul 2005 → Sep 2006 | Plasmodium falciparum malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 2 | NCT00223990 Comparator | Apr 2005 → Apr 2006 | Plasmodium falciparum malaria | U.S. Army Medical Research and Development Command | Completed | Missed primary |
| Phase 2/3 | NCT03264157 Background | Dec 2017 → Mar 2018 | — | Bio Products Laboratory | Completed | Met primary |
| Phase 3 | NCT03143218 Comparator | Apr 2017 → Mar 2020 | Plasmodium falciparum malaria | London School of Hygiene and Tropical Medicine | Completed | No outcome recorded |
| Phase 4 | NCT01365494 Comparator | Jul → Nov 2011 | rabies | Novartis Vaccines | Completed | No outcome recorded |
| Phase 4 | NCT00023504 Comparator | Jun 2002 → May 2017 | immunodeficiency disease | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded Stop: Enrollment |
Press releases naming this drug 4 releases
| Date | Issuer | Release |
|---|---|---|
| 2025-02-07 | Replicate Bioscience | Replicate Bioscience Announces Publication of First-in-Human Data for Its Optimized srRNA Rabies Vaccine in Nature Communications replicatebioscience.com ↗ |
| 2019-12-31 | Bavarian Nordic | Bavarian Nordic Announces Closing of Acquisition of Rabipur/RabAvert and Encepur from GlaxoSmithKline and Updates Year-end Cash Preparedness bavarian-nordic.com ↗ |
| 2019-12-13 | Bavarian Nordic | Bavarian Nordic Receives Antitrust Clearance for Acquisition of Rabipur/RabAvert and Encepur from GlaxoSmithKline bavarian-nordic.com ↗ |
| 2019-11-14 | Bharat Biotech International Limited | Chiron Behring Re-Launches It's Rabies Vaccine As "Chirorab®" bharatbiotech.com ↗ |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 27 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rabipur | “Male or female subjects between 5 and 17 months of age at the time of first vaccination received 3 doses of Rabipur vaccine administered intramuscularly in the left deltoid...” NCT00380393 ↗13“2 or 3 intradermal doses of 0.1 mL PCECV (Rabipur) were administered to 703 schoolchildren on days 0 and 28 or on days 0, 7, and 28.” PMID 17643772 ↗ Aug 2007 “Two group (Zagreb and Essen) will receive Rabipur vaccine IM according to either Zagreb or Essen schedules.” NCT01365494 ↗ “Subjects received Zagreb schedule (2-1-1) i.e. 4 vaccinations of Rabipur at days 1 , 8 and 22” NCT01680016 ↗ |
| Known as | PCECV, Rabipur | “PCECV, Rabipur” NCT01107275 ↗ |
| Known as | RabAvert | “The RABAVERT Vaccine is an inactivated, purified chick embryo cell vaccine (PCECV). It consists of lyophilized rabies virus (strain Flury LEP) that has been propagated in...” NCT04019444 ↗11“We conducted a first-in-human, phase 1, randomized, double-blind, dose-escalation trial comparing ChAd155-RG with a licensed inactivated vaccine (RabAvert) in healthy adults.” PMID 39418686 ↗ Oct 2024 “RabAvert®” NCT02040090 ↗ |
| Known as | Rabies vaccine | “Rabies vaccine (RabAvert): RabAvert Rabies vaccine” NCT00349713 ↗ |
| Known as | RVa | “Imovax (RVi) and Rabavert (RVa) rabies vaccines” NCT02956746 ↗ |
| Modality | Vaccine | “using Rabies vaccine immunization” NCT00023504 ↗ |
| Route | Intramuscular | “administered intramuscular deltoid” NCT00197054 ↗ |